Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-24 @ 3:50 PM
NCT ID:
NCT04405492
Eligibility Criteria:
Common criteria for the 3 populations :
* Persons over 18 years of age
* Beneficiary or person entitled to a social security scheme
Population 1 (Patients) :
* Patients presenting for hospital admission on suspicion of SARS-Cov-2 infection based on the WHO definition and local guidelines
* Patient or relative/trusted person who has been informed about the study and has given informed consent.
Population 2 (Caregivers) :
* Caregivers exposed to COVID-19 in the course of their duties in the clinical departments of the Bicêtre and Paul Brousse hospitals.
* Caregiver who gave informed consent.
Population 3 (Lay Users) :
* Clients presenting themselves in one of the volunteer dispensary pharmacies located in the Île-de-France region, who will be called "lay users".
* Presentation on a study site
Exclusion Criteria:
Common criteria for the 3 populations:
\- Person subject to a justice protection measure
Population 1 (Patients):
* Refusal to participate by the patient / support person or close friend
* Patient not speaking French and not accompanied by a translator
* Patient under guardianship or curatorship
* Person under AME (State medical aid)
Population 2 (Caregivers):
\- Refusal to participate
Population 3 (lay users):
* Refusal to participate
* Person not speaking French and not accompanied by a translator
* Person under AME (State medical aid)
* Person out of state to consent, under guardianship or curatorship
* Pregnant and lactating women
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04405492
Study Brief:
Protocol Section:
NCT04405492